Back
BioMarin Pharmaceutical, Inc. Stock Price Chart
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Sell
47
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$56.85
Seasonality Move:
-1.65%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now-
The current trend is relatively stagnant and BMRN is experiencing slight buying pressure.
BioMarin Pharmaceutical, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.22 | Buy |
| 20-day SMA: | 57.84 | Sell |
| 50-day SMA: | 55.99 | Buy |
| 200-day SMA: | 56.67 | Buy |
| 8-day EMA: | 56.69 | Buy |
| 20-day EMA: | 56.93 | Sell |
| 50-day EMA: | 56.29 | Buy |
| 200-day EMA: | 58.23 | Sell |
BioMarin Pharmaceutical, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 49.87 | Sell |
| Chaikin Money Flow: | 511522 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.66 - 60.38) | Sell |
| Bollinger Bands (100): | (52.55 - 57.43) | Buy |
BioMarin Pharmaceutical, Inc. Technical Analysis
| Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 13 | 14 | 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioMarin Pharmaceutical, Inc. Stock
Is BioMarin Pharmaceutical, Inc. Stock a Buy?
-
BioMarin Pharmaceutical, Inc. share price is 56.85 while BMRN 8-day simple moving average is 56.22, which is a Buy signal.
-
The stock price of BMRN is 56.85 while BioMarin Pharmaceutical, Inc. 20-day SMA is 57.84, which makes it a Sell.
-
BioMarin Pharmaceutical, Inc. 50-day simple moving average is 55.99 while BMRN share price is 56.85, making it a Buy technically.
-
BMRN stock price is 56.85 and BioMarin Pharmaceutical, Inc. 200-day simple moving average is 56.67, creating a Buy signal.
BMRN Technical Analysis vs Fundamental Analysis
Sell
47
BioMarin Pharmaceutical, Inc. (BMRN)
is a Sell
Is BioMarin Pharmaceutical, Inc. a Buy or a Sell?
-
BioMarin Pharmaceutical, Inc. stock is rated a SellThe current BioMarin Pharmaceutical, Inc. [BMRN] share price is $56.85. The Score for BMRN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
BioMarin Pharmaceutical, Inc. Stock Info
Market Cap:
10.9B
Price in USD:
56.85
Share Volume:
1.3M
BioMarin Pharmaceutical, Inc. 52-Week Range
52-Week High:
73.51
52-Week Low:
50.76
Sell
47
BioMarin Pharmaceutical, Inc. (BMRN)
is a Sell
BioMarin Pharmaceutical, Inc. Share Price Forecast
-
What is the BioMarin Pharmaceutical, Inc. stock price today?The BioMarin Pharmaceutical, Inc. stock price is 56.85 USD today.
-
Will BMRN stock go up or go down?BioMarin Pharmaceutical, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is BioMarin Pharmaceutical, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioMarin Pharmaceutical, Inc. is overvalued.
Is BioMarin Pharmaceutical, Inc. Stock a Buy?
-
BioMarin Pharmaceutical, Inc. share price is 56.85 while BMRN 8-day exponential moving average is 56.69, which is a Buy signal.
-
The stock price of BMRN is 56.85 while BioMarin Pharmaceutical, Inc. 20-day EMA is 56.93, which makes it a Sell.
-
BioMarin Pharmaceutical, Inc. 50-day exponential moving average is 56.29 while BMRN share price is 56.85, making it a Buy technically.
-
BMRN stock price is 56.85 and BioMarin Pharmaceutical, Inc. 200-day simple moving average is 58.23, creating a Sell signal.
Fundamental Analysis of BioMarin Pharmaceutical, Inc.
Is BioMarin Pharmaceutical, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.84 per share, and an increase next year of $0.55 per share.
Technical Analysis of BioMarin Pharmaceutical, Inc.
Should I short BioMarin Pharmaceutical, Inc. stock?
-
BMRN Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting BioMarin Pharmaceutical, Inc. is a Buy
-
BioMarin Pharmaceutical, Inc. Relative Strength Index (RSI) is 49.87, which suggest BioMarin Pharmaceutical, Inc. is oversold
-
The Bollinger Bands (25) for BioMarin Pharmaceutical, Inc. is (55.66 - 60.38), which suggest BioMarin Pharmaceutical, Inc. is a Buy
-
The Bollinger Bands (100) for BioMarin Pharmaceutical, Inc. is (52.55 - 57.43), which suggest BioMarin Pharmaceutical, Inc. is a Buy
* BioMarin Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.